← Eichor
Condition: Late Onset Alzheimer Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Late Onset Alzheimer Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

China Cognition and Aging Study
Phase N/A · 65 location(s) · Capital Medical University · NCT03653156
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
NA · 1 location(s) · Massachusetts Institute of Technology · NCT05655195
Multimodal Assesment of Alzheimer Patients
Phase N/A · 1 location(s) · Norwegian University of Science and Technology · NCT06448403
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Diseas
NA · 8 location(s) · Alzheimercentrum Amsterdam · NCT07680335
Late Onset Alzheimer's Disease
Phase N/A · 12 location(s) · Columbia University · NCT05010603
Alzheimer's Disease Genetics Study
Phase N/A · 1 location(s) · Indiana University · NCT00064870
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07509125
NYSCF Scientific Discovery Biobank
Phase N/A · 1 location(s) · New York Stem Cell Foundation Research Institute · NCT06203106
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06561906
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.